某肿瘤医院门诊乳腺癌患者内分泌治疗药物的利用评价

Utilization Evaluation of Endocrine Drug for Outpatients with Breast Cancer Patients in a Tumor Hospital

目的:分析某肿瘤医院门诊乳腺癌患者内分泌治疗用药情况,促进临床合理用药。方法:采用回顾性研究方法,对该院2013年门诊乳腺癌患者内分泌治疗用药情况,应用Excel软件对用药频度(DDDs)、日均费用(DDC)等进行统计、分析。结果:2013年该院门诊使用的乳腺癌内分泌治疗药物主要有10个品种,应用最多的药物是雌激素受体调节剂和芳香化酶抑制剂,促性腺激素释放激素类药物正逐步被临床推广应用,进口类药物使用占主导地位。结论:该肿瘤医院门诊乳腺癌内分泌治疗用药基本合理;用药选择应同时考虑患者意愿,减轻患者经济负担。

OBJECTIVE： To analyze the utilization evaluation of endocrine drugs for outpatients with breast cancer in a tumor hospital, and to promote rational drug use in the clinic. METHODS： By retrospective method, the utilization of endocrine drugs in outpatients with breast cancer in the hospital in 2013 was analyzed statistically by using Excel software in respect of DDDs, DDC, etc. RESULTS： 10 varieties of endocrine drugs were mainly used in outpatient department of the hospital in 2013; estrogen receptor modulators and aromatase inhibitors took up the biggest proportion. LH-RH analogues were gradually applied, and imported ones were the dominant types of drugs. CONCLUSIONS ： It is reasonable to use endocrine drugs in outpatients with breast cancer in the hospital. Drug selection should consider about patients＇ willingness, to reduce the economic burden of patients.